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Whole Exome Sequencing and Homozygosity Mapping
Identify Mutation in the Cell Polarity Protein GPSM2
as the Cause of Nonsyndromic Hearing Loss DFNB82
Tom Walsh,1,4,* Hashem Shahin,2,4 Tal Elkan-Miller,3 Ming K. Lee,1 Anne M. Thornton,1 Wendy Roeb,1
Amal Abu Rayyan,2 Suheir Loulus,2 Karen B. Avraham,3 Mary-Claire King,1 and Moien Kanaan2,*
Massively parallel sequencing of targeted regions, exomes, and complete genomes has begun to dramatically increase the pace of
discovery of genes responsible for human disorders. Here we describe how exome sequencing in conjunction with homozygosity
mapping led to rapid identiﬁcation of the causative allele for nonsyndromic hearing loss DFNB82 in a consanguineous Palestinian
family. After ﬁltering out worldwide and population-speciﬁc polymorphisms from the whole exome sequence, only a single deleterious
mutation remained in the homozygous region linked to DFNB82. The nonsense mutation leads to an early truncation of the G protein
signaling modulator GPSM2, a protein that is essential for maintenance of cell polarity and spindle orientation. In the mouse inner ear,
GPSM2 is localized to apical surfaces of hair cells and supporting cells and is most highly expressed during embryonic development.
Identiﬁcation of GPSM2 as essential to the development of normal hearing suggests dysregulation of cell polarity as amechanism under-
lying hearing loss.Homozygosity mapping in consanguineous kindreds with
nonsyndromic hearing loss has led to the discovery of
more than 50 recessive deafness loci.1 Genomic regions
linked to hearing loss by homozygositymapping are gener-
ally multiple megabases in size and can contain hundreds
of genes. The identiﬁcation of the critical allele from a large
number of candidates has heretofore been an expensive
and time-consuming process. Very recently, advances in
DNA enrichment and next-generation sequencing tech-
nology have made it possible to quickly and cost-
effectively sequence all the genes in the ‘‘exome,’’ the
protein-coding portion of the genome, and then to rapidly
identify alleles responsible for Mendelian disorders.2,3
We applied whole exome sequencing to identify the
gene responsible for nonsyndromic hearing loss DFNB82
in a Palestinian family.4 Hearing loss in affected individ-
uals was evaluated by pure-tone audiometry and was deter-
mined to be sensorineural, prelingual, bilateral, and severe
to profound. (Figure 1A). Vision and vestibular function
were normal, and there were no other ﬁndings on
ophthalmic testing and clinical exam. The DFNB82 region
spans 3.1 Mb on chromosome 1p13.1 and contains 50
annotated protein coding genes and 1 miRNA. The
DFNB82 region partially overlaps with the DFNB32 region
(MIM 608653) deﬁned by a Tunisian family with congen-
ital profound hearing loss.5 The region of overlap contains
ﬁve genes: VAV3, SLC25A4, NBPF4, NBPF6, and FAM102B.
Genomic DNA from individual CG5 (Figure 1B) was ex-
tracted from blood, sonicated to approximately 200 bp
fragments, and used to make a library for paired-end
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from the SureSelect Human All Exon kit (Agilent Technol-
ogies), puriﬁed by streptavidin-bound magnetic beads,
ampliﬁed, and sequenced.6 The exome design covers
38 Mb of human genome corresponding to the exons
and ﬂanking intronic regions of 23,739 genes in the
National Center for Biotechnology Information Con-
sensus CDS database (September 2009 release) and also
covers 700 miRNAs from the Sanger v13 database and
300 noncoding RNAs.7 We generated a total of 5.6 Gb of
sequence as paired-end 76 bp reads from one lane of an
Illumina Genome Analyzer IIX with Illumina pipeline
v.1.6. We used MAQ v.0.7.18 to discard reads of inadequate
sequence quality or depth and to discard those with iden-
tical start and end sites.
In order to identify the allele responsible forDFNB82, we
focused on exonic and ﬂanking intronic variants within
the linkage region on chromosome 1p13.3 between bp
108,307,327 and 111,450,408 (February 2009 human
reference sequence UCSC hg19/GRCh37). Alignment of
the sequence reads in this region revealed that 424 of the
458 targeted exons (93%) had >10 high-quality reads.
The fully evaluated exons include three genes (VAV3,
SLC25A4, and FAM102B) from the DFNB32/DFNB82 over-
lap region. The other two genes in the region (NBPF4 and
NBPF6) could not be evaluated because they lie on adjacent
segmental duplications that are >99% identical.
In the DFNB82 region, 80 variants, all single nucleotide
substitutions, passed our quality thresholds. All 80 substi-
tutions were predicted to be homozygous, as expected
given our SNP-based homozygosity mapping data.4ington, Seattle, WA 98195, USA; 2Department of Life Sciences, Bethlehem
tics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University,
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Figure 1. GPSM2 and Nonsyndromic
Hearing Loss DFNB82 in Palestinian
Family CG
(A) Family CG with inheritance of GPSM2
p.R127X and hearing loss (ﬁlled symbols).
(B) Hearing loss in members of family CG.
The affected individuals are ages 12
(CG11), 14 (CG10), 21 (CG6), and 24
(CG7). For CG20, age 2, brainstem-evoked
response tests showed no response for
stimuli at 90 dB in either ear.
(C) Veriﬁcation by Sanger sequencing of
nonsense mutation c.875C>T (p.R127X)
in GPSM2 (accession number
NM_013296).
(D) Site on the GPSM2 protein of the
p.R127X truncation (arrow). T1 to T7 indi-
cate tetratricopeptide repeats; G1 to G4
indicate GoLoco motifs. The project was
approved by the Human Subjects
Committee of Bethlehem University and
by the Human Subjects Division of the
University of Washington.Of the 80 substitutions, 73 appeared in dbSNP130 and thus
were not considered further and 7 were previously uniden-
tiﬁed (Table 1). None of these seven variants were present
in the sequenced exomes of three unrelated Palestinian
individuals from our series. The seven variants included
ﬁve synonymous substitutions, one missense substitution
(MYBPHL p.I65T), and one nonsense mutation (GPSM2
p.R127X). In order to determine whether the 2 amino
acid altering mutations were previously unidentiﬁed poly-
morphisms in the Palestinian population, we genotyped
each in 192 hearing controls and 192 unrelated probands
with hearing loss. The frequency of MYBPHL p.I65T wasThe American Journal of Happroximately 1.0% both in controls
and in unrelated persons with hearing
loss from this population, suggesting
that it is a benign polymorphism. In
contrast, GPSM2 p.R127X was not
present in controls or in unrelated
cases. GPSM2 p.R127X mutation
segregated as expected with deafness
in family CG (Figure 1A), based on
PCR and Sanger sequencing of all
family members.
The SNP databases include two
entries (rs36018922 and rs34430749)
in exon 4 of GPSM2 that are predicted
to lead to premature truncations.
However, each of these variants was
reported only once, neither was vali-
dated by the reporting source, and
we did not observe either in 768 unre-
lated individuals (384 Palestinians,
192 Caucasians, 192 African Ameri-
cans, data not shown). These entrieswere likely artifacts of alignment errors in short mononu-
cleotide runs.
GPSM2, alsoknownasLGN(Leu-Gly-Asn repeat-enriched
protein) and Pins (humanhomolog ofDrosophila, Partner of
Inscuteable), is a 677 amino acid,Gprotein signalingmodu-
lator.9 It is comprised of seven N-terminal tetratricopeptide
(TPR) motifs, a linker domain,10 and four C-terminal Gai/o-
Loco (GoLoco) motifs that function in guanine nucleotide
exchange.11 The DFNB82mutation is predicted to truncate
the protein between the second and third TPR motifs
(Figure 1D). Analysis of lymphoblast RNA from CG14,
a normal hearing parent and heterozygous carrier ofuman Genetics 87, 90–94, July 9, 2010 91
Table 1. Private Variants in Genes in the DFNB82 Region
Genomic Site (hg19) Variant Gene Amino Acid Effect
chr1: 108,735,196 C>T SLC25A25 K17K Silent
chr1: 109,358,901 A>G AKNAD1 H806H Silent
chr1: 109,394,540 G>A AKNAD1 Y250Y Silent
chr1: 109,440,214 C>T GPSM2 R127X Nonsense; not
present in
Palestinian
controls
chr1: 109,704,542 G>A KIAA1324 A61A Silent
chr1: 109,840,834 A>G MYBPHL I65T Missense;
polymorphic
in Palestinian
controls
chr1: 110,085,767 G>A GPR61 S42S Silentp.R127X, indicates that thenonsense alleleproducesa stable
mutant transcript (see Figure S1 available online).
GPSM2 is widely expressed, but its pattern in the ear has
not previously been described. We evaluated inner ear
sections from embryonic day 16.5 (e16.5), postnatal day
0 (p0), p15, and p60 mice by immunohistochemistry92 The American Journal of Human Genetics 87, 90–94, July 9, 2010with an antibody against Gpsm212 (ProteinTech) (Figure 2;
Figure S2). Staining indicates localization at the apical
surfaces of the hair and supporting cells in the cochlea
(Figures 2C, 2D, 2G, and 2H), utricle (Figures 2F and 2J),
and saccule and cristae (data not shown) of e16.5 and p0
inner ears. In the cochlea, GPSM2 localization extends
throughout the greater epithelial ridge (Figures 2E and
2I). Cochlear hair cells at p0 exhibit an asymmetrical local-
ization of Gpsm2 at the lateral edge, a pattern that is not
present in the e16.5 hair cells. Gpsm2 is also localized in
the pillar cells in p0 inner ears. By p15, Gpsm2 disappears
at the apical surface of the cells, whereas it persists in pillar
cells. In adult mice (p60), Gpsm2 is concentrated speciﬁ-
cally in the head region of the inner pillar cells (Figure S2).
In order to characterize expression of Gpsm2 during
development, we assessed levels of Gpsm2 transcript
expression in the mouse ear by quantitative RT-PCR of
RNA from wild-type C3H mice at ages e16.5, p0, p7, p30,
and p90 (Figure 3). Relative to levels of the internal control
Hprt, Gpsm2 expression decreased rapidly between e16.5
and e30 to a level in adult mice approximately 20% of
the level at birth.
Pins, the Drosophila homolog of GPSM2, has been well
characterized. Pins is an evolutionarily conserved protein.Figure 2. Localization of Gpsm2 in the
Mouse Inner Ear
(A and B) Schematic representation of the
cochlea (A) and utricle (B), one of the
vestibular organs. The inner and outer
hair cells of the cochlea make up the
sensory cells; they are embedded in non-
sensory supporting cells, including theDei-
ters, pillar, and Hensen cells. The utricle
alsocontainshaircells andsupporting cells.
(C–J) Immunoﬂuorescence images of the
cochlea at e16.5 (C and D) and p0 (G and
H) and of the utricle at e16.5 (F) and p0
(J). Gpsm2 (green) is localized at the apical
surface of the hair and supporting cells,
both in the cochlea and utricle and along
the greater epithelial ridge (E and I) in
e16.5 and p0 inner ears. In p0 cochlea, it
is speciﬁcally localized at the lateral ridge
of the hair cell surface. It is also localized
in the pillar cells at this age. Hair cell cyto-
plasm is marked by myosin VI (red), and
the nuclei are marked by DAPI (blue).
Parafﬁn embedded sections were stained
with primary antibodies goat anti-myosin
VI (Santa Cruz Biotechnology) and rabbit
anti-Gpsm2 (ProteinTech; for validation
of the antibody, see 12) and the ﬂuores-
cence-conjugated secondary antibodies
donkey anti-rabbit 488 (Molecular Probes)
and donkey anti-goat cy3 (Sigma). Imaging
was donewith an LSM 510 confocalmicro-
scope (Zeiss). Scale bars represent 5 mm (C,
E–G, I, and J), 2 mm (D), and 2.5 mm (H). All
procedures involving animals met NIH
guidelines and were approved by the
Animal Care and Use Committees of Tel
Aviv University and the University of
Washington.
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Figure 3. Expression of Gpsm2 in the Mouse Inner
Ear during Development
Expression of Gpsm2 transcript at ages e16.5, p0,
1 week, 1 month, and 3 months, determined by
quantitative real-time PCR (Applied Biosystems, Taq-
Man assay Mm00512842). Values represent mean5
standard deviation of samples run in triplicate. The
experiment was repeated twice; a representative
experiment is shown.In Drosophila neuroblasts, Pins regulates apical-basal
spindle orientation and asymmetric cell division.13 In Cae-
norhabditis elegans one-cell embryos, the Pins functional
counterparts GPR-1 and GPR-2 are essential for translating
polarity cues into asymmetric spindle positioning.14
Mammals have two Pins homologs, GPSM1 and GPSM2.
GPSM1 expression is tissue speciﬁc, primarily being en-
riched in the brain, testis, and heart.15 GPSM1 maps to
a locus associated with recessive nonsyndromic deafness
(DFNB79, MIM 613307) but has recently been excluded
as the cause of this hearing loss.16 GPSM2 appears to be
ubiquitously expressed.17
A knockout mouse model of Gpsm2 has recently been
generated18 with premature truncation in the C-terminal
GoLoco motifs but with the TPR repeats predicted to be
intact. Mice homozygous for this truncation (designated
LGNDc/Dc) are viable and fertile. No additional phenotyp-
ing or behavioral studies were described for these mice.
At the cellular level, mitotic orientations within the apical
divisions of the dorsolateral brain of the LGNDc/Dc mice
were random, suggesting that GPSM2 is essential for planar
spindle orientation during apical divisions.18
The establishment and maintenance of cell polarity
involves coordinated regulation of signaling cascades,
membrane trafﬁcking, and cytoskeletal dynamics. Dysre-
gulation of cell polarity can lead to developmental disor-
ders.19 GPSM2, along with G protein alpha and the nuclear
mitotic apparatus protein NuMA, is a major contributor in
establishing and maintaining cellular polarity in yeast,
worms, ﬂies, and mammals.9
In the inner ear, premature truncation of GPSM2may be
associated with defects in cell polarity, which relies on
asymmetric organization of cellular components, scaf-
folding molecules, and structures along the apical-basal
cellular axis. Hair and sensory epithelial cells of the organ
of Corti have polarized structures and functions.20 Hair
cells have a deﬁned apical localization of the stereocilia
that form a hair bundle polarized along their planar axis.
The apical underlying network of actins and the planar
polarity of hair bundles endow hair cells with coordinated
directional response tomechanical signals. These polaritiesThe American Journal of Human Genetics 87, 90–94, July 9, 2010 93l
l
-are examples of cellular differentiation with
asymmetric distribution of molecules that
regulate apical-basal polarity and planar cell
polarity. GPSM2, G protein alpha, and NuMA
are associated with the apical cortical crescent.
Gpsm2 is localized along the apical surface ofthe organ of Corti and vestibular organs at e16.5 and p0
in the mouse. By p0, its localization in hair cells is limited
to the lateral edge. Such a pattern is characteristic of
proteins of the planar cell polarity pathway, such as
Vangl2, Dvl2, and Fz3, where the protein is asymmetrically
localized to one edge of the apical surface of the cells.21
Like Gpsm2, Wnt7a, shown to mediate stereocillary
bundle reorientation, becomes restricted to the pillar cells
with age.22 Pillar cells have been proposed to act as the
organizing center for the orientation of the organ of
Corti.23 We speculate that the establishment of polarity
during cellular differentiation and the maintenance of
proper polarity requires GPSM2 and that loss of GPSM2
function by premature truncation of the GPSM2 pro-
tein would lead to abnormal orientation of hair bundles
and hence to aberrant hair cell transduction and hearing
loss.Supplemental Data
Supplemental Data include two ﬁgures and can be found with this
article online at http://www.ajhg.org.
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